These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28470712)

  • 21. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.
    Lebofsky R; Decraene C; Bernard V; Kamal M; Blin A; Leroy Q; Rio Frio T; Pierron G; Callens C; Bieche I; Saliou A; Madic J; Rouleau E; Bidard FC; Lantz O; Stern MH; Le Tourneau C; Pierga JY
    Mol Oncol; 2015 Apr; 9(4):783-90. PubMed ID: 25579085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cells and DNA for real-time EGFR detection and monitoring of non-small-cell lung cancer.
    He J; Tan W; Ma J
    Future Oncol; 2017 Apr; 13(9):787-797. PubMed ID: 28073294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting circulating tumor DNA in renal cancer: An open challenge.
    Corrò C; Hejhal T; Poyet C; Sulser T; Hermanns T; Winder T; Prager G; Wild PJ; Frew I; Moch H; Rechsteiner M
    Exp Mol Pathol; 2017 Apr; 102(2):255-261. PubMed ID: 28214514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid Biopsies for Assessing Metastatic Melanoma Progression.
    Huynh K; Hoon DS
    Crit Rev Oncog; 2016; 21(1-2):141-54. PubMed ID: 27481010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!
    Fontanilles M; Duran-Peña A; Idbaih A
    Curr Neurol Neurosci Rep; 2018 Mar; 18(3):13. PubMed ID: 29520561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid biopsies.
    Lianidou E; Pantel K
    Genes Chromosomes Cancer; 2019 Apr; 58(4):219-232. PubMed ID: 30382599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.
    Esposito A; Criscitiello C; Trapani D; Curigliano G
    Curr Oncol Rep; 2017 Jan; 19(1):1. PubMed ID: 28110461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classifying circulating tumor cells to monitor cancer progression.
    Economopoulou P; Georgoulias V; Kotsakis A
    Expert Rev Mol Diagn; 2017 Feb; 17(2):153-165. PubMed ID: 28032524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers.
    Yin CQ; Yuan CH; Qu Z; Guan Q; Chen H; Wang FB
    Dis Markers; 2016; 2016():1427849. PubMed ID: 27403030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
    Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
    Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma.
    Cai ZX; Chen G; Zeng YY; Dong XQ; Lin MJ; Huang XH; Zhang D; Liu XL; Liu JF
    Int J Cancer; 2017 Sep; 141(5):977-985. PubMed ID: 28543104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.
    Cheng X; Zhang L; Chen Y; Qing C
    J Ovarian Res; 2017 Nov; 10(1):75. PubMed ID: 29132396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in Circulating Tumor DNA Analysis.
    Perakis S; Auer M; Belic J; Heitzer E
    Adv Clin Chem; 2017; 80():73-153. PubMed ID: 28431643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
    Nordgård O; Tjensvoll K; Gilje B; Søreide K
    Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid biopsies in lung cancer: the new ambrosia of researchers.
    Rolfo C; Castiglia M; Hong D; Alessandro R; Mertens I; Baggerman G; Zwaenepoel K; Gil-Bazo I; Passiglia F; Carreca AP; Taverna S; Vento R; Santini D; Peeters M; Russo A; Pauwels P
    Biochim Biophys Acta; 2014 Dec; 1846(2):539-46. PubMed ID: 25444714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.
    Madic J; Kiialainen A; Bidard FC; Birzele F; Ramey G; Leroy Q; Rio Frio T; Vaucher I; Raynal V; Bernard V; Lermine A; Clausen I; Giroud N; Schmucki R; Milder M; Horn C; Spleiss O; Lantz O; Stern MH; Pierga JY; Weisser M; Lebofsky R
    Int J Cancer; 2015 May; 136(9):2158-65. PubMed ID: 25307450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms.
    Wang J; Bettegowda C
    J Mol Diagn; 2017 Jan; 19(1):24-34. PubMed ID: 27863260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.